MedPath

Measuring Analgesic Interventions

Recruiting
Conditions
Pain
Registration Number
NCT03794362
Lead Sponsor
Julia Finkel
Brief Summary

It is generally recognized that pain assessment and management especially in newborns, children and other nonverbal populations is an unmet need. According to the American Medical Association, "the pediatric population is at risk of inadequate pain management, with age-related factors affecting pain management in children. Children are often given minimal or no analgesia for procedures that would routinely be treated aggressively in adults. Although much is now known about pain management in children, it has not been widely or effectively translated into routine clinical practice". These two factors combine to emphasize the necessity for an objective tool to quantify pain and monitor the effectiveness of analgesia, especially during treatments. Further, it is reported that many patients require a combination of treatments, and it is often necessary to test a variety of treatments before the personal match for treatment is found. The method in place to change the care on a subjective basis is difficult, time consuming, and not easily individualized. This pilot study is part of an ongoing effort to develop a method to objectively assess response to specific analgesic interventions. It specifically aims to discern the impact of analgesic interventions on sensory nerve fiber sensitivity in a diverse patient population.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  1. The subject is 7 to 21 years of age
  2. The subject is receiving an analgesic intervention in the Children's National Medical Center Pain Clinic
  3. The subject is willing and able to provide written informed assent/parental consent to the study participation.
Exclusion Criteria
  1. Eye pathology precluding pupillometry
  2. Patients who are actively using opioids (history of use acceptable). Rationale: opioids constrict the pupil, and therefore concomitant opioid use would bias our results.
  3. Subjects who are or may be pregnant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pupillary Reflex Dilation (PRD) Area under Curve (AUC)0, 15, 30, 45, 60, 90, 120, 180 minutes

The changes that occur in PRD AUC as a response to an analgesic intervention will be investigated. The differences are calculated by comparing the parameters from before the intervention to after the intervention.

Secondary Outcome Measures
NameTimeMethod
Pupillary Light Reflex (PLR) Recovery Time0, 15, 30, 45, 60, 90, 120, 180 minutes

The changes that occur in PLR Recovery Time as a response to an analgesic intervention will be investigated. The differences are calculated by comparing the parameters from before the intervention to after the intervention.

Pupillary Reflex Dilation (PRD) Amplitude0, 15, 30, 45, 60, 90, 120, 180 minutes

The changes that occur in PRD amplitude as a response to an analgesic intervention will be investigated. The differences are calculated by comparing the parameters from before the intervention to after the intervention.

Pupillary Light Reflex (PLR) Latency0, 15, 30, 45, 60, 90, 120, 180 minutes

The changes that occur in PLR Latency as a response to an analgesic intervention will be investigated. The differences are calculated by comparing the parameters from before the intervention to after the intervention.

Pupillary Light Reflex (PLR) Amplitude0, 15, 30, 45, 60, 90, 120, 180 minutes

The changes that occur in PLR Amplitude as a response to an analgesic intervention will be investigated. The differences are calculated by comparing the parameters from before the intervention to after the intervention.

Trial Locations

Locations (1)

Children's National Health System

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath